Hepatitis C Information - SUPERQUANT HCV assay is first test to demonstrate the

SUPERQUANT HCV assay is first test to demonstrate the
the antiviral effects of an FDA approved treatment for chronic Hepatitis C infection CULVER CITY, California., October 8,1997 -- National Genetics Institute today announced

Screening: Hepatitis C Virus Infection
U.S. Preventive Services Task Force Screening for Hepatitis C in Adults Release Date: March 2004 Summary of Recommendations / Supporting Documents Summary of Recommendation The USPSTF recommends against

Dialysis, Viral Hepatitis, and Immunization
Vaccine, August 19, 2002, Vol. 20(25-26):3230-5 Click here for PubMed abstract 6/02 Hepatitis C Infection in Children and Adolescents with End-Stage Renal Disease Authors: Molle ZL, Baqi

Clinical Trial: Safety and Efficacy of the Therapeutic Vaccine GI-5005
Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection This study is currently recruiting patients. Verified by GlobeImmune July 2005 Sponsored by:

MedPage Today - Breaking Medical News - CME
SAN FRANCISCO - Patients with hepatitis C infection who are refractory to pegylated interferon plus ribavirin or who relapse, may benefit from additional therapy with consensus interferon plus